Seven Grand Managers LLC Trims Stock Holdings in Guardian Pharmacy Services, Inc. (NYSE:GRDN)

Seven Grand Managers LLC lowered its position in shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN - Free Report) by 33.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 100,000 shares of the company's stock after selling 49,700 shares during the period. Seven Grand Managers LLC owned 0.16% of Guardian Pharmacy Services worth $2,026,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Barclays PLC bought a new stake in shares of Guardian Pharmacy Services in the 3rd quarter valued at about $311,000. Charles Schwab Investment Management Inc. bought a new stake in shares of Guardian Pharmacy Services during the fourth quarter valued at approximately $544,000. Rhumbline Advisers purchased a new position in shares of Guardian Pharmacy Services in the fourth quarter worth $149,000. New York State Common Retirement Fund boosted its holdings in shares of Guardian Pharmacy Services by 17.9% during the 4th quarter. New York State Common Retirement Fund now owns 278,548 shares of the company's stock valued at $5,643,000 after acquiring an additional 42,368 shares during the last quarter. Finally, Wells Fargo & Company MN raised its stake in Guardian Pharmacy Services by 353.7% during the 4th quarter. Wells Fargo & Company MN now owns 6,715 shares of the company's stock valued at $136,000 after buying an additional 5,235 shares during the last quarter.

Guardian Pharmacy Services Stock Performance

GRDN stock traded down $4.83 during trading on Wednesday, hitting $21.68. 141,046 shares of the company's stock traded hands, compared to its average volume of 145,534. The business has a fifty day simple moving average of $23.02 and a two-hundred day simple moving average of $21.93. Guardian Pharmacy Services, Inc. has a 1 year low of $14.16 and a 1 year high of $26.91.

Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) last posted its quarterly earnings results on Monday, May 12th. The company reported $0.21 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.22 by ($0.01). The business had revenue of $329.31 million for the quarter, compared to analyst estimates of $321.21 million. On average, sell-side analysts anticipate that Guardian Pharmacy Services, Inc. will post 0.87 EPS for the current fiscal year.

Wall Street Analyst Weigh In

GRDN has been the topic of a number of analyst reports. Truist Financial restated a "buy" rating and set a $28.00 target price (up previously from $25.00) on shares of Guardian Pharmacy Services in a research note on Monday. Raymond James set a $28.00 price objective on shares of Guardian Pharmacy Services and gave the company an "outperform" rating in a research report on Wednesday, May 14th.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.